Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Chimeric antigen receptor T cell (CAR-T) therapies are now standard-of-care for several B-cell malignancies, and additional indications are being evaluated. In this review, we survey data on how outcomes after CAR-T therapies vary according to age, race, and ethnicity. We also review the representat...
Saved in:
Main Authors: | Marco Ruella, Guido Ghilardi, Zainul S. Hasanali, Sandra P. Susanibar-Adaniya, Lena E. Winestone, Alfred L. Garfall |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e009349.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formula Student Race Car Chassis Design and Analysis
by: Yiğit Alp Oymak, et al.
Published: (2021-06-01) -
Cécile Cottenet (ed.), Race, Ethnicity and Publishing in America
by: Sandrine Ferré-Rode
Published: (2019-12-01) -
Race/Ethnicity, Gender, Weight Status, and Colorectal Cancer Screening
by: Heather Bittner Fagan, et al.
Published: (2011-01-01) -
Model-Based Optimization of Velocity Strategy for Lightweight Electric Racing Cars
by: Mirosław Targosz, et al.
Published: (2018-01-01) -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
by: Ugo Testa, et al.
Published: (2024-02-01)